Health Notices




NEW ZEALAND GAZETTE, No. 104 — 18 NOVEMBER 2016

Social Housing. The amendments are intended to ensure that applicants for social housing who are homeless or are living in emergency housing are appropriately assessed in terms of the adequacy of their current living situation for the purposes of assessing their level of housing need. The amendments move the need to consider the level of overcrowding in applicants’ current living situations and their security of tenure from the ‘suitability’ factor to the ‘adequacy’ factor for the purposes of assessing their level of housing need. The amendments also make any issues of family or other violence relating to an applicant’s current living situations an explicit factor to be considered by the social housing agency when having regard to ‘suitability’ in assessing housing need. This instrument is a disallowable instrument for the purposes of the Legislation Act 2012.

1 New Zealand Gazette, 17 April 2014, No. 41, page 1203

2016-go6510

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Allmercap
Mercaptopurine 20mg/mL
Oral suspension
Link Pharmaceuticals Limited
Nova Laboratories Limited, Leicester, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 3.125mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 6.25mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 12.5mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 25mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Brilinta
Ticagrelor 60mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Södertälje, Sweden

Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Brimica Genuair
Aclidinium bromide 0.4mg equivalent to aclidinium 0.34mg
Formoterol fumarate dihydrate 0.012mg
Powder for inhalation
A. Menarini New Zealand Pty Limited
Industrias Farmacéuticas Almirall SA (IFA), Barcelona, Spain

Dated this 15th day of November 2016.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

15



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 104





✨ LLM interpretation of page content

🏥 Ministerial Direction on Eligibility for Social Housing Amendment 2016 (continued from previous page)

🏥 Health & Social Welfare
9 November 2016
Housing, Social Housing, Eligibility, Amendments, Emergency Housing, Family Violence

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
15 November 2016
Medicines, Distribution, Consent, Pharmaceuticals
  • CHRIS JAMES, Group Manager, Medsafe, Ministry of Health